Since cancer cells usually express higher ROS levels than non-transformed cells, the alteration of expression and activity of glycolytic enzyme such as PKM2 and GAPDH may represent a necessary adaptation to enhance reducing power of the tumor cells by redirecting the metabolites into PPP for production of NADPH. This evidence concerns the gene PKM and cancer.